Related Experiment Video

Updated: Sep 26, 2026

Detection of Abnormal Prion Protein by Immunohistochemistry
06:38

Detection of Abnormal Prion Protein by Immunohistochemistry

Published on: May 5, 2023

Different chromogranin immunoreactivity between prion and a-beta amyloid plaque

Claire-Marie Rangon1, Stéphane Haïk, Baptiste A Faucheux

  • 1INSERM Unité 338, 5 rue Blaise Pascal, 67084 Strasbourg Cedex, France.

Neuroreport
|April 15, 2003
PubMed

Insights

Chromogranin B (CgB) is linked to prion protein deposits in Creutzfeldt-Jakob disease (CJD) brain lesions. This suggests CgB plays a role in CJD neurodegeneration, unlike Chromogranin A (CgA).

Area of Science:

  • Neuroscience
  • Neuropathology
  • Molecular Biology

Background:

  • Creutzfeldt-Jakob disease (CJD) pathology involves spongiform change, neuronal loss, and microglial activation.
  • Microglia are implicated in prion-induced neurodegeneration, but the molecules mediating neuron-microglia interactions remain unclear.
  • Chromogranins (Cg) are proteins that can activate microglia, potentially leading to neurotoxicity.

Purpose of the Study:

  • To investigate the immunoreactive patterns of Chromogranin A (CgA) and Chromogranin B (CgB) in CJD brain lesions.
  • To compare these patterns with those observed in Alzheimer's disease.
  • To elucidate the potential role of chromogranins in CJD pathogenesis.

Main Methods:

  • Immunohistochemical analysis of CJD and Alzheimer's disease brain tissues.
  • Detection and localization of CgA and CgB immunoreactivity.
  • Correlation of chromogranin patterns with specific pathological hallmarks (prion protein deposits, Abeta plaques).

Main Results:

  • Chromogranin B (CgB) immunoreactivity was selectively found associated with prion protein deposits in CJD.
  • Chromogranin A (CgA) immunoreactivity was exclusively observed in Abeta plaques, not associated with prion deposits.
  • These findings indicate distinct localization patterns for CgA and CgB in neurodegenerative diseases.

Conclusions:

  • The selective association of CgB with prion deposits suggests a specific role in the CJD neurodegenerative process.
  • The distinct localization implies that amyloid protein influences chromogranin secretion.
  • CgB emerges as a potential key molecule in the interaction between neurons and microglia in CJD.

More Related Videos

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting10:51

Consensus Brain-derived Protein, Extraction Protocol for the Study of Human and Murine Brain Proteome Using Both 2D-DIGE and Mini 2DE Immunoblotting

Published on: April 10, 2014

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...